$25.78
-0.37-1.41%
Last update: Nov 10, 7:59 PM

The average analyst price target for Fulgent Genetics is $28.75, 10.6% above the current price. Of 3 analysts, 2 rate it Buy and 1 Hold. Targets range from $25 to $35. The latest change came on Nov 10, 2026, when Piper Sandler raised its price target on Fulgent Genetics from $19 to $25 and kept a Neutral rating.
Price Target Range — 10 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months